Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Mankind Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543904NSE Symbol: MANKINDP/E(TTM):60.18
ISIN Demat:INE634S01028Div & Yield %:0EPS(TTM):43.84
Book Value(Rs):354.6937544Market Cap ( Cr.):108891.88Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 9497.808629.258127.157486.225523.184794.41
Excise Duty0.000.000.000.000.000.00
Net Sales9497.808629.258127.157486.225523.184794.41
Other Income 554.44374.03162.78203.81154.5093.85
Stock Adjustments 13.5048.20-267.89365.27254.2544.51
Total Income10065.749051.488022.048055.305931.934932.77
EXPENDITURE :      
Raw Materials 2610.392618.312576.872886.712036.421617.42
Power & Fuel Cost88.9780.9162.0060.3647.1646.49
Employee Cost 2131.671921.091701.381462.761167.42991.47
Other Manufacturing Expenses 203.70145.78113.6293.5756.7157.73
Selling and Administration Expenses 1770.411518.781539.071378.52905.53696.80
Miscellaneous Expenses 143.09125.69168.47131.08192.07185.06
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure6948.236410.566161.406013.004405.313594.98
Operating Profit3117.512640.921860.652042.301526.621337.79
Interest 372.2816.9328.2347.548.2311.10
Gross Profit2745.232623.991832.421994.761518.391326.69
Depreciation378.01335.26269.58123.3378.1961.77
Profit Before Tax2367.222288.731562.841871.431440.201264.92
Tax469.93411.33291.64429.03346.99341.81
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-48.191.2422.9452.988.84-35.11
Reported Net Profit1945.481876.161248.261389.421084.37958.23
Extraordinary Items 254.30105.8929.0262.0730.0918.58
Adjusted Net Profit1691.181770.271219.241327.351054.28939.65
Adjst. below Net Profit 4.98-6.66-4.86-0.79-1.56-69.15
P & L Balance brought forward9763.977894.476624.905236.273747.133160.50
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.000.000.000.000.00302.44
P & L Balance carried down11714.439763.977868.306624.904829.953747.13
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.00755.00
Earnings Per Share-Unit Curr47.1546.8331.1634.6827.0723.92
Earnings Per Share(Adj)-Unit Curr47.1546.83NANANANA
Book Value-Unit Curr354.83242.21194.31163.27118.1891.15